puromycin aminonucleoside has been researched along with Cirrhosis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bollinger, C; Fitch, RM; Hayes, K; Warner, E; Wright, D | 1 |
Abraham, VC; Doyle, K; Gopalakrishnan, M; Gopalakrishnan, S; Lee, CH; Leys, L; Ma, J; McGaraughty, SP; Nikkel, AL; Olson, L; Pratt, S; Putman, B; Salte, K; Su, Z; Widomski, D; Zhu, CZ | 1 |
Ding, W; Li, J; Wang, H; Yu, L; Zhao, Y | 1 |
Doi, N; Hotta, O; Miyazawa, S; Natori, Y; Nishikawa, K | 1 |
Bertho-Ruault, C; de Gouville, AC; Gellibert, F; Grygielko, ET; Huet, S; Laping, NJ; Mathews, N; Nguyen, VL; Patikis, A; Woolven, J | 1 |
Bustos, C; Egido, J; González-Cuadrado, S; Guijarro, C; Ortiz, A; Plaza, JJ; Ruiz-Ortega, M | 1 |
Drukker, A; Eddy, AA | 1 |
Buch, S; Eddy, AA; Jones, CL; Liu, E; McCulloch, L; Post, M | 1 |
8 other study(ies) available for puromycin aminonucleoside and Cirrhosis
Article | Year |
---|---|
Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Biomarkers; Disease Models, Animal; Female; Fibrosis; Glomerulosclerosis, Focal Segmental; Injections; Kidney; Membrane Glycoproteins; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley | 2020 |
A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injury.
Topics: Adenosine Kinase; Animals; Basement Membrane; Cytoprotection; Fibrosis; Kidney; Male; Mice; Podocytes; Protein Kinase Inhibitors; Puromycin Aminonucleoside; Rats | 2016 |
Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis.
Topics: Angelica sinensis; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Astragalus Plant; China; Drugs, Chinese Herbal; Enalapril; Fibrosis; Humans; Kidney; Male; Medicine, Chinese Traditional; Nephrosis; Phytotherapy; Plant Preparations; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Regression Analysis; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats.
Topics: Animals; Fibrosis; Gene Expression; Heparin; Interleukin-4; Kidney; Male; Mast Cells; Puromycin Aminonucleoside; Rats; Rats, Mutant Strains; RNA, Messenger; Transforming Growth Factor beta | 2004 |
Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor.
Topics: Activin Receptors, Type I; Acute Disease; Administration, Oral; Animals; Benzamides; Collagen Type I; Collagen Type I, alpha 1 Chain; Dimethylnitrosamine; Fibrosis; Kidney; Liver Cirrhosis; Male; Models, Molecular; Protein Serine-Threonine Kinases; Puromycin Aminonucleoside; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; RNA, Messenger; Structure-Activity Relationship | 2006 |
Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis.
Topics: Animals; Chemokine CCL2; Chemokine CXCL10; Chemokines; Chemokines, CXC; Connective Tissue; Connective Tissue Cells; Cyclosporine; Cytokines; Fibroblasts; Fibrosis; Kidney; Nephritis, Interstitial; Puromycin Aminonucleoside; Rats; RNA, Messenger; Up-Regulation | 1996 |
Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol; Collagen; Female; Fibronectins; Fibrosis; Kidney; Lipid Peroxides; Lipoproteins, LDL; Liver; Lovastatin; Macrophages; Microscopy, Fluorescence; Nephrotic Syndrome; Organ Size; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta; Treatment Failure; Vitamin E | 1998 |
Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis.
Topics: Albuminuria; Animals; Chronic Disease; Creatinine; Disease Models, Animal; Extracellular Matrix Proteins; Female; Fibrosis; Gene Expression; Glycoproteins; Macrophages; Metalloendopeptidases; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Inbred Lew; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta | 1991 |